Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. (Q51472878)

5 April 2018

title

Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. (English)

1 reference

5 April 2018

0 references

1 reference

coronary artery disease

1 reference

based on heuristic

inferred from title

author

Arnold von Eckardstein

2

object named as

Arnold von Eckardstein

1 reference

5 April 2018

Anette E Buyken

1

1 reference

5 April 2018

Helmut Schulte

3

1 reference

5 April 2018

Paul Cullen

4

1 reference

5 April 2018

Gerd Assmann

5

1 reference

5 April 2018

publication date

1 April 2007

1 reference

5 April 2018

European Journal of Cardiovascular Prevention and Rehabilitation

published in

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

230-236

1 reference

5 April 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Diabetes and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by i

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3280142037

10.1097/HJR.0B013E3280142037

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

17446801

1 reference

5 April 2018